CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Growing prevalence of respiratory disorders
4.1.2. Rapid growth in the geriatric population and high prevalence of tobacco smoking
4.1.3. Early diagnosis of respiratory disorders & technological advancements
4.1.4. Shift from traditional cylinders to portable concentrators
4.1.5. Preference towards home-based oxygen therapy
4.2. Market Restraints & Challenges
4.2.1. Availability of low-cost alternatives by local manufacturers
4.2.2. Stringent regulatory guidelines causing delays in product approval
4.3. Market Opportunities
4.3.1. Emerging markets
4.3.2. Increasing usage of telemedicine and tele monitoring
CHAPTER 5 GLOBAL OXYGEN THERAPY EQUIPMENT MARKET – BY PRODUCT
5.1. Oxygen Source Equipment
5.1.1. Oxygen Concentrators
5.1.1.1 Fixed Oxygen Concentrators
5.1.1.2 Portable Oxygen Concentrators
5.1.2. Liquid Oxygen Devices
5.1.3. Oxygen Cylinders
5.2. Oxygen Delivery Devices
5.2.1. Oxygen Masks
5.2.2. Nasal Cannulas
5.2.3. Venturi Masks
5.2.4. Non-Rebreather Masks
5.2.5. Bag Valve Masks
5.2.6. Other Devices
CHAPTER 6 GLOBAL OXYGEN THERAPY EQUIPMENT MARKET – BY PORTABILITY
6.1. Stationary Oxygen Therapy Devices
6.2. Portable Oxygen Therapy Devices
CHAPTER 7 GLOBAL OXYGEN THERAPY EQUIPMENT MARKET – BY APPLICATION
7.1. COPD
7.2. Asthma
7.3. Cystic Fibrosis
7.4. Respiratory Distress Syndrome
7.5. Pneumonia
7.6. Other Diseases
CHAPTER 8 GLOBAL OXYGEN THERAPY EQUIPMENT MARKET – BY END USER
8.1. Home Care Settings
8.2. Hospitals
8.3. Ambulatory Surgical Centers & Physician Offices
CHAPTER 9 GLOBAL OXYGEN THERAPY EQUIPMENT MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. Asia Pacific
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL OXYGEN THERAPY EQUIPMENT MARKET - COMPANY PROFILES
10.1. Linde Healthcare (A Division of Linde Group)
10.2. Care fusion Corporation
10.3. Becton, Dickinson and Company
10.4. Taiyo Nippon Sanso Corporation
10.5. Smiths Medical (A Division of Smiths Group PLC)
10.6. Drägerwerk AG & Co. KGaA
10.7. Teleflex Incorporated
10.8. Invacare Corporation
10.9. Chart Industries, Inc.
10.10. Fisher & Paykel Healthcare Corporation Limited
10.11. Inogen, Inc.
10.12. Philips Respironics, Inc.
10.13. DeVilbiss Healthcare
10.14. Maquet Medical Systems
10.15. Allied Healthcare
CHAPTER 11 GLOBAL OXYGEN THERAPY EQUIPMENT MARKET - COMPETITIVE LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
